We favored breast cancer for our studies because Kaplan-Meier survival analysis of the TCGA breast cancer cohort revealed that high, rather than the expected low KANK1 expression correlates with a poor survival rate of breast cancer patients. This evidence concerns the gene KANK1 and breast carcinoma.